Renejix is a leading CDMO accelerating the development and manufacturing of critical new medicines in the small molecule oral dosage space. We combine cutting-edge technologies with a team of highly skilled experts to deliver top-notch solutions for oral small molecule development and manufacturing. With a focus on innovation, quality, and efficiency in development sciences, delivery technologies, and multi-modality manufacturing we are dedicated to helping our clients bring their molecules from concept to commercialization.